Transgenic Group (TSE:2342) ROE % Adjusted to Book Value: -5.01% (As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
60 GF Score
Price 円214.00
GF Value 円257.65
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group ROE % Adjusted to Book Value?

Transgenic Group TSE:2342 -0.93% 60 ROE % Adjusted to Book Value is -5.01% as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 60/100 and a GF Value™ of 円257.65 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Transgenic Group's ROE % for the quarter that ended in Mar. 2026 was -4.46%. Transgenic Group's PB Ratio for the quarter that ended in Mar. 2026 was 0.89. Transgenic Group's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -5.01%.

Transgenic Group ROE % Adjusted to Book Value Related Terms

Transgenic Group ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Transgenic Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group ROE % Adjusted to Book Value Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.07 -7.02 0.10 -31.95 -1.82

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.19 -9.01 -54.41 1.65 -5.01

TSE:2342 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Transgenic Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transgenic Group ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Transgenic Group's ROE % Adjusted to Book Value falls into.


TSE:2342
60GF Score
Transgenic Group Inc TSE:2342
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group ROE % Adjusted to Book Value Calculation

Transgenic Group's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-1.62% / 0.89
=-1.82%

Transgenic Group's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.46% / 0.89
=-5.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -5.01% mean?
Transgenic Group (TSE:2342) has a ROE % Adjusted to Book Value of -5.01% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Transgenic Group and its competitors.
Is Transgenic Group's ROE % Adjusted to Book Value too high?
Transgenic Group's current ROE % Adjusted to Book Value is -5.01%. Overall, Transgenic Group has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's ROE % Adjusted to Book Value compare to VRTX and REGN?
Transgenic Group's ROE % Adjusted to Book Value of -5.01% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Transgenic Group and its competitors. Transgenic Group's current ROE % Adjusted to Book Value is -5.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.65, compared to a current price of 円214.00 — trading 16.9% below its estimated fair value. The current ROE % Adjusted to Book Value is -5.01%. Transgenic Group's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current ROE % Adjusted to Book Value is -5.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円214.00 is trading 16.9% below its estimated GF Value™ of 円257.65. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • ROE % Adjusted to Book Value: -5.01%
  • GF Value™: 円257.65 vs. price of 円214.00 (16.9% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
60GF Score

Get the complete analysis for TSE:2342

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円214.00
Price
円257.65
GF Value